318 related articles for article (PubMed ID: 6577220)
1. Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis.
Go RC; King MC; Bailey-Wilson J; Elston RC; Lynch HT
J Natl Cancer Inst; 1983 Sep; 71(3):455-61. PubMed ID: 6577220
[TBL] [Abstract][Full Text] [Related]
2. Genetic epidemiology of breast cancer and associated cancers in high-risk families. II. Linkage analysis.
King MC; Go RC; Lynch HT; Elston RC; Terasaki PI; Petrakis NL; Rodgers GC; Lattanzio D; Bailey-Wilson J
J Natl Cancer Inst; 1983 Sep; 71(3):463-7. PubMed ID: 6577221
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
4. [The importance of genetic factors for development of breast cancer].
Chang-Claude J; Eby N; Becher H
Zentralbl Gynakol; 1994; 116(12):660-9. PubMed ID: 7846977
[TBL] [Abstract][Full Text] [Related]
5. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families.
Sellers TA; King RA; Cerhan JR; Chen PL; Grabrick DM; Kushi LH; Oetting WS; Vierkant RA; Vachon CM; Couch FJ; Therneau TM; Olson JE; Pankratz VS; Hartmann LC; Anderson VE
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1051-7. PubMed ID: 10613336
[TBL] [Abstract][Full Text] [Related]
6. Genetic epidemiology of breast cancer: segregation analysis of 200 Danish pedigrees.
Williams WR; Anderson DE
Genet Epidemiol; 1984; 1(1):7-20. PubMed ID: 6544234
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of susceptibility to breast cancer.
Hulka BS
Prog Clin Biol Res; 1996; 395():159-74. PubMed ID: 8895988
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
[TBL] [Abstract][Full Text] [Related]
9. Cigarette smoking increases risk for breast cancer in high-risk breast cancer families.
Couch FJ; Cerhan JR; Vierkant RA; Grabrick DM; Therneau TM; Pankratz VS; Hartmann LC; Olson JE; Vachon CM; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):327-32. PubMed ID: 11319172
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families.
Osorio A; Barroso A; Martínez B; Cebrián A; San Román JM; Lobo F; Robledo M; Benítez J
Br J Cancer; 2000 Apr; 82(7):1266-70. PubMed ID: 10755399
[TBL] [Abstract][Full Text] [Related]
11. Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes.
Machado PM; Brandão RD; Cavaco BM; Eugénio J; Bento S; Nave M; Rodrigues P; Fernandes A; Vaz F
J Clin Oncol; 2007 May; 25(15):2027-34. PubMed ID: 17513806
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods.
Sellers TA; Anderson VE; Potter JD; Bartow SA; Chen PL; Everson L; King RA; Kuni CC; Kushi LH; McGovern PG
Genet Epidemiol; 1995; 12(4):417-29. PubMed ID: 8536958
[TBL] [Abstract][Full Text] [Related]
14. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
Goshen R; Chu W; Elit L; Pal T; Hakimi J; Ackerman I; Fyles A; Mitchell M; Narod SA
Gynecol Oncol; 2000 Dec; 79(3):477-81. PubMed ID: 11104623
[TBL] [Abstract][Full Text] [Related]
15. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history.
Nelson CL; Sellers TA; Rich SS; Potter JD; McGovern PG; Kushi LH
Genet Epidemiol; 1993; 10(4):235-44. PubMed ID: 8224804
[TBL] [Abstract][Full Text] [Related]
16. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
17. [Hereditary predisposition for cancer of the breast and the ovary].
Lalle P; Stoppa-Lyonnet D; Mazoyer S; Rio P; Girodet C; Hardouin A; Narod SA; Sobol H; Bignon YJ
Bull Cancer; 1993 Oct; 80(10):857-65. PubMed ID: 8204923
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
19. Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes.
Kaufman DJ; Beaty TH; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1045-52. PubMed ID: 14578141
[TBL] [Abstract][Full Text] [Related]
20. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
